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S(S)-Hydroxyicosatetraenoate s imulates human polymorphonuclear neutrophils (PMNs) to raise their cytosolic calcium. 
It also potentiates the cells’ degranulation responses to platelet-activating factor and diacylglycerols. We synthesized 
S(R)-hydroxyicosatetraenoate nd found it to be 20-lOO-fold weaker than the natural isomer in these assays. Thus, the 
arachidonic acid metabolite activates PMNs by a stereospecific possibly receptor-mediated mechanism. 
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1. INTRODUCTION 
Stimulated human polymorphonuclear neutro- 
phils (PMNs) rapidly metabolize their resident 
phospholipids into a series of signaling molecules 
[ 11. They release arachidonate from phospholipids 
and oxygenate it to S(S)-HETE and LTB4; dea- 
cylate 1-0-alkyl-Zacyl-GPC and acetylate the lyso 
intermediate forming PAF; and cleave phos- 
phatidylinositol and phosphatidylcholine at the 
sn-3 position to yield diacylglycerol [2-41. LTB4, 
PAF and diacylglycerol directly stimulate a 
number of PMN responses uch as degradulation 
and superoxide anion generation by binding to 
specific receptors (the receptor for diacylglycerol is 
protein kinase C). S(S)-HETE, contrastingly, lacks 
appreciable intrinsic-activity in these assays. 
However, it does enhance the potency and power 
of PAF and diacylglycerol in stimulating function 
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eicosatetraenoate; S(R)-HETE, (S(R)-hydroxy-6,8,11,14- 
E,Z,Z,Z-eicosatetraenoate; LTB4, leukotriene B4; PAF, pla- 
telet-activating factor; PMA, 4,8-phorbol-12-myristate-13- 
acetate; diCs, 1,2-dioctanoylglycerol; BSA, bovine serum 
albumin; [Ca2+]i, cytosolic free Ca2+ concentration 
[5-g]. Thus, S(S)-HETE may play a unique role in 
stimulus-response coupling by regulating the ef- 
ficacy of its companion (i.e., concurrently formed) 
mediators. The mechanisms involved in these 
bioactions of S(S)-HETE, therefore, are of par- 
ticular interest. Recently, S(S)-HETE has been 
shown to stimulate calcium mobilization in PMNs 
[8,9]. This effect, which does not require the 
presence of a second mediator, appears at least 
partly responsible for 5(S)-HETE-induced poten- 
tiation of PMN responses to PAF and diacyl- 
glycerol. Nevertheless, important questions about 
the bioactions of 5-HETE still remain unanswered. 
Among these are uncertainties about structural 
specificity. It is known that 15-hydroxyicosate- 
traenoate is bioinactive whereas 5,20-dihydroxyi- 
cosatetraenoate and 5,15-dihydroxyicosatetraeno- 
ate are 30-fold and lOO-fold, respectively, weaker 
than S(S)-HETE [6,8-lo]. However, these com- 
pounds differ from S(S)-HETE not only in 
hydroxy residues but also in the positions and 
geometries of their double bonds, their 3-dimen- 
sional foldings, and their aqueous solubilities. 
Unlike S(S)-HETE, they may not enter PMNs to 
any appreciable extent [lo]. Ideal structural com- 
parisons should be made with compounds more 
closely matched in physicochemical characteristics. 
Accordingly, we have prepared and assessed the 
bioactivity of S(R)-HETE. 
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2. MATERIALS AND METHODS 
2.1. Reagents and buffers 
Arachidonic acid (Nu-Chek, Elysian, MN); trichloro- 
methylchloroformate (Fluka, Buchs, Switzerland); cytochalasin 
B and fatty acid-free BSA (Sigma, St. Louis, MO); Fura-2 pen- 
tapotassium salt and Fura-2 acetoxymethyl ester and diCs 
(Molecular Probes, Junction City, OR); and 1,5-diazabi- 
cyclo[5.4.0]undecene, dehydroabietylamine~ .trichlorosilane, 
triethylamine and 4-dimethylaminopyridine (Aidrich, Mil- 
wauke, WS) were purchased from the indicated vendors; PAF 
was obtained as previously described [5]. All dilutibns of 5(S)- 
HETE, 5(R)-HETE, PAF and diCs were made in a modified [5] 
Hanks' buffer containing fatty acid-free BSA (2:5 mg/ml). 
Dilutions of PMA were made in dimethylsulphoxide'(DMSO). 
The final concentration of DMSO in samples was 0.5%. 
2.2. Preparation of 5(3)- and 5(R)-HETEs 
The stereoisomers of 5-HETE were prepared by the pro- 
cedure of Corey and Hashimoto [11] with the following 
changes: (i) trichloromethylchloroformate was used as a 
substitute for phosgene gas to prepare isocyanates of the 
5-HETEs and (ii) the diastereomeric urethane derivatives of 
5-HETE methyl ester were separated by normal phase HPLC 
[hexane/isopropanol/glacial acetic acid (995"4:1, v/v), 
3 ml/min; 0.75 x 30 cm#-Porasil column]. Products were iden- 
tified, analyzed and checked for purity by TLC; normal and 
reve~se-15hase HPLC [10]; ultraviolet, infrared and nuclear 
magneticresonance spectroscopy; and polarimetry (i.e., the 
more polar carbamate, which yielded the 5(S)-HETE enan- 
tiomer, had a rotation of [od~ 3 + 42.7 ° [c = 1.4, benzene] and 
the less polar carbamate, which yielded the 5(R)-HETE, had a 
rotation of [cr]~ 3 + 6.6 ° [c = 2.4, benzene]). 
2.3. Degranulation assay 
Cells (1.3 x 106) were incubated in 0.5 ml buffer (37°C; 
1.4 mM CaClz) for 20 rain; treated with 2.5 #g cytochalasin B 
for 2-4 rain; and challenged simultaneously with varying con- 
centrations of the stimuli (PAF, PMA or diCs) plus either 5(S)- 
HETE or 5(R)-HETE for 5 or 15 min. The samples were placed 
on ice, centrifuged and the supernatant fluid assayed for 
lysozyme (EC 3.2.1.17) and fl-glucuronidase (EC 3.2.1.21) as 
described [5]. Results are reported as net enzyme release 
(_+ SE), i.e., the percentage of total enzyme released by 
stimulated cells minus that released by unstimulated, but other- 
wise identically treated, ceils. 
2.4. Cytosolic alcium measurements 
PMNs were loaded with Fura-2 acetoxymethyl ester, washed, 
and then stimulated [8]. Results are reported as the mean _+ SE 
of the maximal fluorescence emission ratio (340/380 nm). 
3. RESULTS AND DISCUSSION 
In  agreement  w i th  prev ious  observat ions  [5], 
5 (S ) -HETE (5 -500  nM)  d id  not  induce  PMNs to  
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Fig. 1. The effect of 5-HETE stereoisomers on PAF-induced net release of lysozyme (upper panels) and ~-glucuronidase (lower panels) 
by PMNs. Shaded bars represent responses elicited by PAF alone; adjacent unshaded bars give the responses induced by PAF in the 
presence of increasing concentrations of 5(S)-HETE (left panels) and 5(R)-HETE (right panels). Cells (1.3 x 106/0.5 ml) were 
preincubated with 1.4 mM CaClz for 20 min, treated with 2.5 #g cytochalasin B, and then challenged simultaneously with PAF and 
5(S)-HETE or 5(R)-HETE. Results are reported as the mean + SE for 10-13 separate xperiments. Note that the concentrations for 
5(S)-HETE (left panels) are 10-fold higher than those of 5(R)-HETE (right panels). 
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Table 1 
November 1988 
Effect of 5-HETE stereoisomers on the PMN degranulation response to PMA and diG 
Stimulus S(S)-HETE (LLM) S(R)-HETE GM) 
(nM) 
0 0.05 5.0 0.5 5.0 
PMA (1) 18.8 + 0.9b 24.1 + 2.2’ 28.3 f 2.2’ 21.9 + 1.8 22.6 f 2.4 
PMA (3.2) 22.7 + 2.3 ‘27.1 + 1.0’ 31.9 + 0.7’ 25.1 k 0.8 25.9 f 3.3 
diCa (3200) 2.5 + 1.8 2.1 + 1.3 9.8 + 2.4’ 2.8 + 1.8 1.7 * 0.9 
diG (10000) 7.6 + 1.5 7.6 + 1.2 14.6 + 1.3’ 6.0 k 1.6 11.3 * 1.0’ 
a PMNs (1.3 x lO”/O.S ml of buffer) were incubated with cytochalasin B (2.5 fig) for 2-4 min 
and then challenged for 15 min with the indicated concentrations of stimulus and 5-HETE 
stereoisomer 
b Net lysozyme release + SE for 3-4 separate experiments. The two 5-HETE preparations 
similarly influenced release of @-glucuronidase 
’ Indicates values that are significantly (r, < 0.05, Student’s paired t-test) higher than those 
found in cells treated withstimulus~albne 
release their granule-bound enzymes. S(R)-HETE 
(50-5000 nM) was likewise without effect. 
However, as depicted in the two left panels of 
fig.1, both compounds produced a substantial 
enhancement of PAF-induced degranulation. The 
potentiating effects of the unnatural stereoisomer, 
S(R)-HETE, however, were >20-lOO-fold weaker 
than those elicited by 5(S)-HETE. The 5-HETE 
stereoisomers demonstrated similar potency dif- 
ferences in enhancing the PMN-degranulating ac- 
tions of two protein kinase C activators, PMA and 
diCs (table 1). 
Fig.2 illustrates the effect of the 5-HETE 
stereoisomers on the maximal fluorescence emis- 
sion ratio (340/380 nm), a direct measurement of 
[Ca*+]i, in Fura-Zloaded PMN. We previously 
reported that the biosynthetic S(S)-HETE, at 
5 PM, elevated [Ca’+]i from basal levels (-80 nM) 
to around 250-350 nM within 15 s. After 15 s, 
[Ca’+]i declined and reached pre-stimulatory levels 
in 2.5-5 min [8,9]. Similar calcium transients were 
observed with the chemically synthesized 5-HETEs 
(not shown). S(S)-HETE, however, was again 
-20-50-fold more potent than S(R)-HETE in in- 
ducing the response. 
Our technique for synthesizing 5-HETE 
stereoisomers required resolving a diastereomeric 
mixture of carbamylated 5-HETEs into respective 
precursors of 5(s)- and S(R)-HETE by HPLC. 
This step did not afford perfect resolution: the 
final products may be cross-contaminated by 
l-3%. The bioactions of S(R)-HETE found here, 
therefore, may reflect this cross-contamination. (A 
racemic mixture of 5-HETE was almost as potent 
as S(S)-HETE. Hence, S(R)-HETE did not inhibit 
S(S)-HETE.) In any event, our results indicate that 
S(S)-HETE is at least 20-lOO-fold more potent 
than S(R)-HETE. This suggests that the various ac- 
tions of S(S)-HETE may proceed via a common, 
stereospecific, and possibly receptor-mediated 
mechanism. We have accumulated other evidence 
favoring this: the receptor uncoupling agent, per- 
tussis toxin, inhibits the calcium mobilizing actions 
of S(S)-HETE; and S(S)-HETE, while down- 
regulating PMNs to a second 5(S)-HETE 
challenge, does not similarly down-regulate 
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Fig.2. The effect of S(S)-HETE (circles) and S(R)-HETE 
(squares) on the maximal fluorescence emission ratio 
(3401380 nm) of Fura-Zloaded PMNs. Each point represents 
the mean f SE for 5-8 separate xperiments. 
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responses to LTB4 or PAF in the calcium mobiliz- 
ing assay [9]. However, the receptor hypothesis ob- 
viously needs more direct support. We have 
examined PMNs and PMN membranes for the 
specific binding of [3H]5(s)-HETE and [3H]S(s)- 
HETE methyl ester. Unfortunately, the prepara- 
tions rapidly and quantitatively metabolized both 
ligands even at 4°C. This has completely interfered 
with our binding assessment. Nevertheless, the 
results reported here support further efforts to 
define the putative 5(S)-HETE receptor. Given the 
unique bioactions expressed by S(S)-HETE, such 
receptors seem sure to have novel transduction 
mechanisms and influences upon the PAF- and 
diacylglycerol-induced intracellular events pro- 
moting function. 
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